• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单纯疱疹病毒诱导细胞融合不被其融合抑制复合物所抑制。

Induction of cell-cell fusion by ectromelia virus is not inhibited by its fusion inhibitory complex.

机构信息

Department of Infectious Diseases, Israel Institute for Biological Research, Ness-Ziona, Israel.

出版信息

Virol J. 2009 Sep 29;6:151. doi: 10.1186/1743-422X-6-151.

DOI:10.1186/1743-422X-6-151
PMID:19785778
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2760862/
Abstract

BACKGROUND

Ectromelia virus, a member of the Orthopox genus, is the causative agent of the highly infectious mousepox disease. Previous studies have shown that different poxviruses induce cell-cell fusion which is manifested by the formation of multinucleated-giant cells (polykaryocytes). This phenomenon has been widely studied with vaccinia virus in conditions which require artificial acidification of the medium.

RESULTS

We show that Ectromelia virus induces cell-cell fusion under neutral pH conditions and requires the presence of a sufficient amount of viral particles on the plasma membrane of infected cells. This could be achieved by infection with a replicating virus and its propagation in infected cells (fusion "from within") or by infection with a high amount of virus particles per cell (fusion "from without"). Inhibition of virus maturation or inhibition of virus transport on microtubules towards the plasma membrane resulted in a complete inhibition of syncytia formation. We show that in contrast to vaccinia virus, Ectromelia virus induces cell-cell fusion irrespectively of its hemagglutination properties and cell-surface expression of the orthologs of the fusion inhibitory complex, A56 and K2. Additionally, cell-cell fusion was also detected in mice lungs following lethal respiratory infection.

CONCLUSION

Ectromelia virus induces spontaneous cell-cell fusion in-vitro and in-vivo although expressing an A56/K2 fusion inhibitory complex. This syncytia formation property cannot be attributed to the 37 amino acid deletion in ECTV A56.

摘要

背景

作为正痘病毒属的一员,细小病毒可引起高度传染性的鼠痘疾病。先前的研究表明,不同的痘病毒会诱导细胞-细胞融合,其表现为多核巨细胞(多倍体细胞)的形成。该现象已广泛研究了痘苗病毒在需要人工酸化介质的条件下的情况。

结果

我们表明,在中性 pH 条件下,细小病毒可诱导细胞-细胞融合,并且需要在感染细胞的质膜上存在足够数量的病毒颗粒。这可以通过感染复制病毒及其在感染细胞中的繁殖(“从内部”融合)或通过感染每细胞大量的病毒颗粒(“从外部”融合)来实现。病毒成熟的抑制或病毒向质膜的微管运输的抑制导致合胞体形成的完全抑制。我们表明,与痘苗病毒相反,细小病毒诱导细胞-细胞融合与血凝特性无关,并且与其融合抑制复合物 A56 和 K2 的细胞表面表达无关。此外,在致死性呼吸道感染后,还在小鼠肺部检测到细胞-细胞融合。

结论

尽管表达 A56/K2 融合抑制复合物,但细小病毒在体外和体内诱导自发的细胞-细胞融合。这种合胞体形成特性不能归因于 ECTV A56 的 37 个氨基酸缺失。

相似文献

1
Induction of cell-cell fusion by ectromelia virus is not inhibited by its fusion inhibitory complex.单纯疱疹病毒诱导细胞融合不被其融合抑制复合物所抑制。
Virol J. 2009 Sep 29;6:151. doi: 10.1186/1743-422X-6-151.
2
Mutations Near the N Terminus of Vaccinia Virus G9 Protein Overcome Restrictions on Cell Entry and Syncytium Formation Imposed by the A56/K2 Fusion Regulatory Complex.痘苗病毒 G9 蛋白 N 端附近的突变克服了 A56/K2 融合调节复合物对细胞进入和合胞体形成的限制。
J Virol. 2020 May 4;94(10). doi: 10.1128/JVI.00077-20.
3
Experimental Evolution To Isolate Vaccinia Virus Adaptive G9 Mutants That Overcome Membrane Fusion Inhibition via the Vaccinia Virus A56/K2 Protein Complex.实验进化以分离通过痘苗病毒 A56/K2 蛋白复合物克服膜融合抑制的痘苗病毒 G9 适应性突变体。
J Virol. 2020 May 4;94(10). doi: 10.1128/JVI.00093-20.
4
Expression of the A56 and K2 proteins is sufficient to inhibit vaccinia virus entry and cell fusion.A56和K2蛋白的表达足以抑制痘苗病毒的进入和细胞融合。
J Virol. 2009 Feb;83(4):1546-54. doi: 10.1128/JVI.01684-08. Epub 2008 Nov 26.
5
N1L is an ectromelia virus virulence factor and essential for in vivo spread upon respiratory infection.N1L 是一种细小病毒的毒力因子,对于呼吸道感染时的体内传播是必需的。
J Virol. 2011 Apr;85(7):3557-69. doi: 10.1128/JVI.01191-10. Epub 2011 Jan 26.
6
Loss of Actin-Based Motility Impairs Ectromelia Virus Release In Vitro but Is Not Critical to Spread In Vivo.肌动蛋白依赖的运动能力丧失会损害体外的水疱性口炎病毒释放,但对体内传播并不关键。
Viruses. 2018 Mar 5;10(3):111. doi: 10.3390/v10030111.
7
Association of vaccinia virus fusion regulatory proteins with the multicomponent entry/fusion complex.痘苗病毒融合调节蛋白与多组分进入/融合复合体的关联
J Virol. 2007 Jun;81(12):6286-93. doi: 10.1128/JVI.00274-07. Epub 2007 Apr 4.
8
Vaccinia virus A56/K2 fusion regulatory protein interacts with the A16 and G9 subunits of the entry fusion complex.痘苗病毒A56/K2融合调节蛋白与进入融合复合体的A16和G9亚基相互作用。
J Virol. 2008 Jun;82(11):5153-60. doi: 10.1128/JVI.00162-08. Epub 2008 Mar 19.
9
Ectromelia virus N1L is essential for virulence but not dissemination in a classical model of mousepox.在鼠痘经典模型中,痘苗病毒N1L对毒力至关重要,但对病毒传播并非必需。
Virus Res. 2017 Jan 15;228:61-65. doi: 10.1016/j.virusres.2016.11.017. Epub 2016 Nov 16.
10
An ectromelia virus profilin homolog interacts with cellular tropomyosin and viral A-type inclusion protein.一种埃可病毒肌动蛋白结合蛋白同源物与细胞原肌球蛋白和病毒A型包涵体蛋白相互作用。
Virol J. 2007 Jul 24;4:76. doi: 10.1186/1743-422X-4-76.

引用本文的文献

1
First Diagnosed Case of Camelpox Virus in Israel.以色列首例骆驼痘病毒确诊病例。
Viruses. 2018 Feb 13;10(2):78. doi: 10.3390/v10020078.
2
Active vaccination with vaccinia virus A33 protects mice against lethal vaccinia and ectromelia viruses but not against cowpoxvirus; elucidation of the specific adaptive immune response.用牛痘病毒 A33 进行主动免疫接种可保护小鼠免受致命性牛痘病毒和细疹病毒的侵害,但不能免受牛痘病毒的侵害;阐明了特定的适应性免疫反应。
Virol J. 2013 Jul 10;10:229. doi: 10.1186/1743-422X-10-229.
3
Loss of cytoskeletal transport during egress critically attenuates ectromelia virus infection in vivo.

本文引用的文献

1
Expression of the A56 and K2 proteins is sufficient to inhibit vaccinia virus entry and cell fusion.A56和K2蛋白的表达足以抑制痘苗病毒的进入和细胞融合。
J Virol. 2009 Feb;83(4):1546-54. doi: 10.1128/JVI.01684-08. Epub 2008 Nov 26.
2
The vaccinia virus fusion inhibitor proteins SPI-3 (K2) and HA (A56) expressed by infected cells reduce the entry of superinfecting virus.受感染细胞表达的痘苗病毒融合抑制蛋白SPI-3(K2)和HA(A56)可减少超感染病毒的进入。
Virology. 2008 Oct 25;380(2):226-33. doi: 10.1016/j.virol.2008.07.020. Epub 2008 Aug 28.
3
Vaccinia virus A56/K2 fusion regulatory protein interacts with the A16 and G9 subunits of the entry fusion complex.
细胞骨架运输在出芽过程中的缺失严重削弱了体内的水疱性口炎病毒感染。
J Virol. 2012 Jul;86(13):7427-43. doi: 10.1128/JVI.06636-11. Epub 2012 Apr 24.
4
The vaccinia virus A56 protein: a multifunctional transmembrane glycoprotein that anchors two secreted viral proteins.牛痘病毒 A56 蛋白:一种多功能跨膜糖蛋白,锚定两种分泌型病毒蛋白。
J Gen Virol. 2011 Sep;92(Pt 9):1971-1980. doi: 10.1099/vir.0.030460-0. Epub 2011 Jun 29.
痘苗病毒A56/K2融合调节蛋白与进入融合复合体的A16和G9亚基相互作用。
J Virol. 2008 Jun;82(11):5153-60. doi: 10.1128/JVI.00162-08. Epub 2008 Mar 19.
4
The pathogenesis of the acute exanthems; an interpretation based on experimental investigations with mousepox; infectious ectromelia of mice.急性疹病的发病机制;基于小鼠痘实验研究的解读;小鼠传染性缺肢畸形
Lancet. 1948 Dec 11;2(6537):915-20. doi: 10.1016/s0140-6736(48)91599-2.
5
Tail scarification with Vaccinia virus Lister as a model for evaluation of smallpox vaccine potency in mice.以痘苗病毒李斯特株进行尾部划痕接种作为评估小鼠天花疫苗效力的模型。
Vaccine. 2007 Nov 7;25(45):7743-53. doi: 10.1016/j.vaccine.2007.09.023. Epub 2007 Sep 29.
6
Association of vaccinia virus fusion regulatory proteins with the multicomponent entry/fusion complex.痘苗病毒融合调节蛋白与多组分进入/融合复合体的关联
J Virol. 2007 Jun;81(12):6286-93. doi: 10.1128/JVI.00274-07. Epub 2007 Apr 4.
7
Vaccinia virus entry into cells via a low-pH-dependent endosomal pathway.痘苗病毒通过低pH依赖的内体途径进入细胞。
J Virol. 2006 Sep;80(18):8899-908. doi: 10.1128/JVI.01053-06.
8
Abl collaborates with Src family kinases to stimulate actin-based motility of vaccinia virus.Abl与Src家族激酶协同作用,刺激痘苗病毒基于肌动蛋白的运动。
Cell Microbiol. 2006 Feb;8(2):233-41. doi: 10.1111/j.1462-5822.2005.00613.x.
9
The cowpox virus fusion regulator proteins SPI-3 and hemagglutinin interact in infected and uninfected cells.牛痘病毒融合调节蛋白SPI-3和血凝素在感染和未感染的细胞中相互作用。
Virology. 2006 Mar 30;347(1):88-99. doi: 10.1016/j.virol.2005.11.012. Epub 2005 Dec 27.
10
Poxvirus entry and membrane fusion.痘病毒进入与膜融合。
Virology. 2006 Jan 5;344(1):48-54. doi: 10.1016/j.virol.2005.09.037.